Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Int J Drug Policy. 2015 Jul 26;26(10):911–921. doi: 10.1016/j.drugpo.2015.07.004

Table 5.

Random-effects meta-regression results.

Stage-constant FPR
Stage-specific FPR
CC incidence rate
(per 1,000 PYs)
Factor F0→F4 F0→F1 F1→F2 F2→F3 F3→F4






β SE p β SE p β SE p β SE p β SE P β SE p
Age at infection 0.011 0.006 0.111 −0.012 0.024 0.704 0.017 0.028 0.654 −0.038 0.085 0.733 −0.182 0.192 0.517 1.487 1.526 0.362
Duration of infection −0.003 0.002 0.114 −0.007 0.006 0.437 0.002 0.008 0.808 −0.021 0.020 0.485 −0.055 0.044 0.430 0.213 0.577 0.723
Males (%) 0.128 0.079 0.154 −0.398 0.321 0.432 0.626 −0.407 0.367 0.172 1.170 0.907 −3.310 2.356 0.394 −4.003 23.012 0.867
Recruitment location
  non-clinical setting (ref. cat.) (ref. cat.) (ref. cat.) (ref. cat.) (ref. cat.) (ref. cat.)
  Clinical setting −0.022 0.014 0.161 0.059 0.060 0.504 −0.004 0.059 0.959 0.056 0.330 0.894 0.280 0.490 0.670 −2.678 4.901 0.602
Constant −0.140 0.150 0.386 0.755 0.763 0.503 −0.787 0.894 0.541 1.053 2.438 0.741 7.157 6.077 0.448 −21.622 46.591 0.657

No. of reports 11 6 6 6 6 12